Form 4: Zeo ScientifiX Director Ian T. Bothwell Acquires and Disposes of Series C Preferred Stock

Sentiment:

SEC Form 4 Filing


Director Ian T. Bothwell of Zeo ScientifiX, Inc. engaged in transactions involving Series C Preferred stock on December 30, 2024.

Summary

  • Ian T. Bothwell, a director, 10% owner, and Interim CEO & CFO of Zeo ScientifiX, Inc., filed a Form 4.
  • The filing reports a transaction on December 30, 2024, involving Series C Preferred stock.
  • Mr. Bothwell acquired 50 shares of Series C Preferred stock at a price of $0.
  • He then disposed of 50 shares of Series C Preferred stock.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing and does not indicate positive or negative sentiment. It is a neutral report of transactions.

Industry Context

Form 4 filings are a standard part of regulatory compliance for company insiders, providing transparency into their transactions in company securities. This filing is specific to Zeo ScientifiX and does not provide broader industry context.

Comparison to Industry Standards

  • Form 4 filings are a standard regulatory requirement for all publicly traded companies in the United States.
  • The transactions reported are specific to the individual and company and do not provide a basis for comparison to other companies.

Stakeholder Impact

  • This filing provides transparency to shareholders regarding insider transactions.

Key Dates

DateDescription
12/30/2024Date of the transaction involving Series C Preferred stock and the date of the filing.

Keywords

Form 4, Zeo ScientifiX, Series C Preferred Stock, Insider Trading, Beneficial Ownership, Ian T. Bothwell, Director, Interim CEO, CFO

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.